These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Evaluation of the Du Pont Theophylline Assay adapted to a centrifugal analyzer.
    Author: Boeckx RL, Munson ST.
    Journal: Ther Drug Monit; 1985; 7(1):95-100. PubMed ID: 3887672.
    Abstract:
    We evaluated the Du Pont Theophylline Assay, a particle-enhanced turbidimetric inhibition immunoassay (PETINIA) for the measurement of theophylline in human serum. The procedure was applied to the Cobas-Bio centrifugal analyzer, and was compared to an enzyme immunoassay (EMIT) method and a high performance liquid chromatographic (HPLC) procedure. Day-to-day precision was 3.7% (1 SD coefficient of variation) at 7.1 mg/L, 3.3% at 17.7 mg/L, and 3.9% at 27.8 mg/L. The assay was linear up to 40 mg/L, and the correlation between the PETINIA, EMIT, and HPLC methods was good [PETINIA/EMIT: y = 0.94x + 0.63, r = 0.98, Syx = 1.13; PETINIA/HPLC: y = 1.00x - 0.89, r = 0.99, Syx = 0.66, where Syx is the standard deviation of the residual error of regression], when evaluated using specimens from 135 patients receiving theophylline. No interference from hemolysis, lipemia, icterus, or other methylxanthines was observed. Of the major metabolites of theophylline, only 1,3-dimethyluric acid showed any significant cross-reactivity (2.1 mg/L apparent theophylline at 20 mg/L 1,3-dimethyluric acid). The method is reliable and cost-effective for the measurement of theophylline in serum.
    [Abstract] [Full Text] [Related] [New Search]